These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 24492363)

  • 1. Isavuconazole therapy protects immunosuppressed mice from mucormycosis.
    Luo G; Gebremariam T; Lee H; Edwards JE; Kovanda L; Ibrahim AS
    Antimicrob Agents Chemother; 2014; 58(4):2450-3. PubMed ID: 24492363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis with Isavuconazole or Posaconazole Protects Immunosuppressed Mice from Pulmonary Mucormycosis.
    Gebremariam T; Alkhazraji S; Baldin C; Kovanda L; Wiederhold NP; Ibrahim AS
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis.
    Gebremariam T; Wiederhold NP; Alqarihi A; Uppuluri P; Azie N; Edwards JE; Ibrahim AS
    J Antimicrob Chemother; 2017 Feb; 72(2):462-466. PubMed ID: 27798213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful isavuconazole salvage therapy in a patient with invasive mucormycosis.
    Ervens J; Ghannoum M; Graf B; Schwartz S
    Infection; 2014 Apr; 42(2):429-32. PubMed ID: 24217961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis.
    Gebremariam T; Gu Y; Singh S; Kitt TM; Ibrahim AS
    J Antimicrob Chemother; 2021 Sep; 76(10):2636-2639. PubMed ID: 34263306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report.
    Cornu M; Bruno B; Loridant S; Navarin P; François N; Lanternier F; Amzallag-Bellenger E; Dubos F; Mazingue F; Sendid B
    BMC Pharmacol Toxicol; 2018 Dec; 19(1):81. PubMed ID: 30522521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.
    Marty FM; Ostrosky-Zeichner L; Cornely OA; Mullane KM; Perfect JR; Thompson GR; Alangaden GJ; Brown JM; Fredricks DN; Heinz WJ; Herbrecht R; Klimko N; Klyasova G; Maertens JA; Melinkeri SR; Oren I; Pappas PG; Ráčil Z; Rahav G; Santos R; Schwartz S; Vehreschild JJ; Young JH; Chetchotisakd P; Jaruratanasirikul S; Kanj SS; Engelhardt M; Kaufhold A; Ito M; Lee M; Sasse C; Maher RM; Zeiher B; Vehreschild MJGT;
    Lancet Infect Dis; 2016 Jul; 16(7):828-837. PubMed ID: 26969258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy.
    Jenks JD; Salzer HJ; Prattes J; Krause R; Buchheidt D; Hoenigl M
    Drug Des Devel Ther; 2018; 12():1033-1044. PubMed ID: 29750016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus Infection.
    Gebremariam T; Wiederhold NP; Fothergill AW; Garvey EP; Hoekstra WJ; Schotzinger RJ; Patterson TF; Filler SG; Ibrahim AS
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7815-7. PubMed ID: 26369977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent.
    Miceli MH; Kauffman CA
    Clin Infect Dis; 2015 Nov; 61(10):1558-65. PubMed ID: 26179012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isavuconazole As Successful Salvage Therapy for Mucormycosis in Pediatric Patients.
    Ashkenazi-Hoffnung L; Bilavsky E; Levy I; Grisaru G; Sadot E; Ben-Ami R; Novikov A; Fischer S; Nahum E; Scheuerman O
    Pediatr Infect Dis J; 2020 Aug; 39(8):718-724. PubMed ID: 32251256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden.
    Floros L; Kuessner D; Posthumus J; Bagshaw E; Sjölin J
    BMC Infect Dis; 2019 Feb; 19(1):134. PubMed ID: 30744563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isavuconazole: A new broad-spectrum azole. Part 2: pharmacokinetics and clinical activity.
    Ledoux MP; Denis J; Nivoix Y; Herbrecht R
    J Mycol Med; 2018 Mar; 28(1):15-22. PubMed ID: 29551442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal efficacy of isavuconazole and liposomal amphotericin B in a rabbit model of Exserohilum rostratum meningoencephalitis: A preclinical paradigm for management of CNS phaeohyphomycosis.
    Petraitis V; Petraitiene R; Katragkou A; Maung BBW; Moradi PW; Sussman-Straus GE; Naing E; Kovanda LL; Finkelman MA; Walsh TJ
    Med Mycol; 2021 Feb; 59(2):189-196. PubMed ID: 33313821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
    Riley TT; Muzny CA; Swiatlo E; Legendre DP
    Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isavuconazole: A Review in Invasive Aspergillosis and Mucormycosis.
    Shirley M; Scott LJ
    Drugs; 2016 Nov; 76(17):1647-1657. PubMed ID: 27766566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost of treating mucormycosis with isavuconazole compared with standard therapy in the UK.
    Bagshaw E; Kuessner D; Posthumus J; Escrig C; Blackney M; Heimann SM; Cornely OA
    Future Microbiol; 2017 May; 12():515-525. PubMed ID: 28191796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of invasive mucormycosis with isavuconazole in pediatric patients.
    Barg AA; Malkiel S; Bartuv M; Greenberg G; Toren A; Keller N
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27281. PubMed ID: 29932282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isavuconazole treatment of a patient with disseminated mucormycosis.
    Peixoto D; Gagne LS; Hammond SP; Gilmore ET; Joyce AC; Soiffer RJ; Marty FM
    J Clin Microbiol; 2014 Mar; 52(3):1016-9. PubMed ID: 24403304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New pharmacological opportunities for the treatment of invasive mould diseases.
    Ledoux MP; Toussaint E; Denis J; Herbrecht R
    J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i48-i58. PubMed ID: 28355467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.